Similar articles

• A brief account of viral vectors and their promise for gene therapy.

  Finer M, Glorioso J. Finer M, et al. Gene Ther. 2017 Jan;24(1):1-2. doi: 10.1038/gt.2016.71. Gene Ther. 2017. PMID: 28123184 No abstract available.
• Gene therapy: hopes, hypes, and hurdles.

  Verma IM. Verma IM. Mol Med. 1994 Nov;1(1):2-3. Mol Med. 1994. PMID: 8790596 Free PMC article. No abstract available.
• Gendicine: the first commercial gene therapy product.

  Wilson JM. Wilson JM. Hum Gene Ther. 2005 Sep;16(9):1014-5. doi: 10.1089/hum.2005.16.1014. Hum Gene Ther. 2005. PMID: 16149899 Chinese, English. No abstract available.
• Improved adenoviral vectors: cautious optimism for gene therapy.

  Channon KM, George SE. Channon KM, et al. QJM. 1997 Feb;90(2):105-9. doi: 10.1093/qjmed/90.2.105. QJM. 1997. PMID: 9068800 Review. No abstract available.
• Gene therapy: novel treatments for polyneuropathy and chronic pain.

  Mata M, Glorioso JC, Fink DJ. Mata M, et al. Curr Neurol Neurosci Rep. 2004 Jan;4(1):1-2. doi: 10.1007/s11910-004-0001-0. Curr Neurol Neurosci Rep. 2004. PMID: 14683620 Review. No abstract available.